Vanda Pharmaceuticals Announces Presentations at SLEEP 2024
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at SLEEP 2024, to be held in Houston, TX from June 1 through...
Source: prnewswire.com
Presentation Session News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Presentation Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Presentation Session Today - Breaking & Trending Today
NewAmsterdam Pharma to Present New Clinical and Preclinical Data Highlighting Obicetrapib's ... | Region
-- Presentations include new data from OCEAN, ROSE, and ROSE2 Phase 2 clinical trials, demonstrating obicetrapib’s impact on key lipid and lipoprotein biomarkers --
Source: eagletribune.com
Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-1
BE-101 is Company’s Lead Program in Hemophilia B; IND Filing Anticipated in Mid-2024Be Bio Appoints Glenn Pierce, M.D., Ph.D., Hemophilia Physician-Researcher and Advocate, to its Scientific Advisory BoardPreclinical Study Findings Shared in Oral Presentation During 65th Annual Meeting of the American Society of Hem...
Source: pharmiweb.com
Foresee Pharmaceuticals Selected for Late-Breaking Oral Presentation on its Aderamastat Phase 2 Study Results at the European Respiratory Society (ERS) International Congress 2023
/PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced today that the company has been selected for a late-breaking oral presentation on...
Source: prnewswire.com